These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20559604)

  • 1. Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test.
    Cafini F; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; González N; Coronel P; Prieto J
    Rev Esp Quimioter; 2010 Jun; 23(2):72-5. PubMed ID: 20559604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the ceftazidime-imipenem antagonism test (CIAT) to detect and confirm the presence of inducible AmpC beta-lactamases among enterobacteriaceae.
    Cantarelli VV; Inamine E; Brodt TC; Secchi C; Cavalcante BC; Pereira Fde S
    Braz J Infect Dis; 2007 Apr; 11(2):237-9. PubMed ID: 17625769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a novel fluorogenic chimeric analog for the detection of third-generation cephalosporin resistant bacteria.
    Park MJ; Park YJ; Oh EJ; Chang J; Kim Y; Yu J; Park KG; Ahn DR
    J Microbiol Methods; 2016 Dec; 131():161-165. PubMed ID: 27784641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of boronic acid inhibition with different cephalosporins against Escherichia coli producing AmpC β-lactamases.
    Upadhyay S; Sen MR; Bhattacharjee A
    J Med Microbiol; 2011 May; 60(Pt 5):691-3. PubMed ID: 21292860
    [No Abstract]   [Full Text] [Related]  

  • 8. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H; Poirel L; Nordmann P
    J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
    Mouton RP; Bongaerts GP; van Gestel MH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():147-52. PubMed ID: 19802978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
    Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
    J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
    Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
    J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
    Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
    Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae.
    Hope R; Potz NA; Warner M; Fagan EJ; Arnold E; Livermore DM
    J Antimicrob Chemother; 2007 Jan; 59(1):110-3. PubMed ID: 17090552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of AmpC beta-lactamase expression and sequence in biochemically atypical ceftazidime-resistant Enterobacteriaceae from paediatric patients.
    Avison MB; Underwood S; Okazaki A; Walsh TR; Bennett PM
    J Antimicrob Chemother; 2004 Apr; 53(4):584-91. PubMed ID: 15014062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of plasmid-mediated AmpC beta-lactamases among Enterobacteriaceae in Algiers hospitals.
    Iabadene H; Messai Y; Ammari H; Alouache S; Verdet C; Bakour R; Arlet G
    Int J Antimicrob Agents; 2009 Oct; 34(4):340-2. PubMed ID: 19570655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae.
    Kaneko K; Okamoto R; Nakano R; Kawakami S; Inoue M
    J Clin Microbiol; 2005 Jun; 43(6):2955-8. PubMed ID: 15956430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
    Bethel CR; Hujer AM; Helfand MS; Bonomo RA
    FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.
    Kang CI; Pai H; Kim SH; Kim HB; Kim EC; Oh MD; Choe KW
    J Antimicrob Chemother; 2004 Dec; 54(6):1130-3. PubMed ID: 15486080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the susceptibility of AmpC-producing bacteria to third-generation cephalosporins].
    Jirsa R; Kolár M
    Klin Mikrobiol Infekc Lek; 2009 Dec; 15(6):214-6. PubMed ID: 20077399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.